Dr Reddy’s Laboratories announced on Friday that it has launched a generic medication in the US market
By The Capital
On
Dr Reddy’s Laboratories announced on Friday that it has launched a generic medication in the US market. The medication is used to treat a wide variety of bacterial…
Dr Reddy’s Laboratories announced on Friday that it has launched a generic medication in the US market. The medication is used to treat a wide variety of bacterial infections and is called Doxycycline Capsules (40 mg). According to the Hyderabad-based drug maker, their product is a therapeutic generic equivalent of Oracea capsules (40 mg) approved by the US Food and Drug Administration (USFDA). On Friday, the company’s shares ended 0.71 per cent up at Rs 6,332.85 apiece on the BSE.
Tags
Latest Posts
Lanka Dinakar meets Lokesh
14 Dec 2024
Lanka Dinakar, Chairman of the Twenty Points Programme Implementation, met with the State Education and IT Minister Nara Lokesh